Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Dynavax (DVAX) Tops Q3 EPS by 14c; Offers FY23 Revenue Guidance
November 2, 2023 4:20 PM EDTDynavax (NASDAQ: DVAX) reported Q3 EPS of $0.10, $0.14 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $69.51 million versus the consensus estimate of $60.3 million.
GUIDANCE:
Dynavax sees FY2023 revenue of $210-220 million, versus the consensus of $224.7... More
